Literature DB >> 2349593

Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke.

F Giubilei1, G L Lenzi, V Di Piero, C Pozzilli, P Pantano, S Bastianello, C Argentino, C Fieschi.   

Abstract

We investigated 32 patients with completed ischemic stroke less than or equal to 6 hours after the onset of symptoms by means of computed tomography, cerebral angiography, and technetium-99m-labeled hexamethylpropyleneamine oxime single-photon emission computed tomography to study cerebral blood flow. Follow-up computed tomography and cerebral blood flow studies were performed 1 week and 1 month after admission. Poor outcome at 1 month was evident in 18 (78%) of the 23 patients with severe neurologic deficit on admission and in 11 (92%) of the 12 patients with severe hypoperfusion in the affected hemisphere on admission. All 10 patients with severe impairment of both neurologic status and cerebral blood flow had a poor outcome at 1 month. We detected severe hypoperfusion in patients with large lesions on computed tomograms or cerebral artery occlusions on angiograms. Cerebral blood flow had increased at the 1-week follow-up despite different clinical outcomes. Our data provide evidence that early evaluation of cerebral blood flow with single-photon emission computed tomography is useful to detect subgroups of patients with different clinical outcomes during the acute phase of ischemic stroke.

Entities:  

Mesh:

Year:  1990        PMID: 2349593     DOI: 10.1161/01.str.21.6.895

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Motor recovery after acute ischaemic stroke: a metabolic study.

Authors:  V Di Piero; F M Chollet; P MacCarthy; G L Lenzi; R S Frackowiak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

2.  SPECT and rehabilitation: which role?

Authors:  U P Guerra
Journal:  Ital J Neurol Sci       Date:  1998-10

3.  Quantitative measurement of cerebral blood flow by (99m)Tc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options.

Authors:  A Umemura; T Suzuka; K Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

4.  Comparison of mean cerebral transit time and single-photon emission tomography for estimation of stroke outcome.

Authors:  K R Lees; C J Weir; G J Gillen; A K Taylor; C Ritchie
Journal:  Eur J Nucl Med       Date:  1995-11

Review 5.  Clinical Imaging of the Penumbra in Ischemic Stroke: From the Concept to the Era of Mechanical Thrombectomy.

Authors:  Lucie Chalet; Timothé Boutelier; Thomas Christen; Dorian Raguenes; Justine Debatisse; Omer Faruk Eker; Guillaume Becker; Norbert Nighoghossian; Tae-Hee Cho; Emmanuelle Canet-Soulas; Laura Mechtouff
Journal:  Front Cardiovasc Med       Date:  2022-03-09

Review 6.  Imaging of cerebral ischemia: from acute stroke to chronic disorders.

Authors:  May Nour; David S Liebeskind
Journal:  Neurol Clin       Date:  2013-10-23       Impact factor: 3.806

7.  Technetium-99m HMPAO SPET in acute supratentorial ischaemic infarction, expressing deficits as millilitre of zero perfusion.

Authors:  R A Dierckx; A Dobbeleir; B A Pickut; L Timmermans; I Dierckx; A Vervaet; J Vandevivere; W Deberdt; P P De Deyn
Journal:  Eur J Nucl Med       Date:  1995-05

8.  Anoxic injury-associated cerebral hyperperfusion identified with arterial spin-labeled MR imaging.

Authors:  J M Pollock; C T Whitlow; A R Deibler; H Tan; J H Burdette; R A Kraft; J A Maldjian
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-01       Impact factor: 3.825

Review 9.  Imaging for prediction of functional outcome and assessment of recovery in ischemic stroke.

Authors:  Wolf-Dieter Heiss; Chelsea S Kidwell
Journal:  Stroke       Date:  2014-03-04       Impact factor: 7.914

10.  Relative risk values of age, acrolein, IL-6 and CRP as markers of periventricular hyperintensities: a cross-sectional study.

Authors:  Arata Abe; Yasuhiro Nishiyama; Mina Harada-Abe; Seiji Okubo; Masayuki Ueda; Masahiro Mishina; Yasuo Katayama
Journal:  BMJ Open       Date:  2014       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.